A61P 19/08
Drugs for skeletal disorders: for bone diseases
Official title: for bone diseases, e.g. rachitism, Paget's disease
A61P19/08 (Drugs for skeletal disorders: for bone diseases) appears on 12,037 US grants and 17,934 published applications in this corpus.
Search patents in A61P- Granted patents
- 12,037
- Published applications
- 17,934
- Assignees
- 4,506
- Inventors
- 27,103
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1987 | 4 | 0 |
| 1988 | 2 | 0 |
| 1989 | 4 | 0 |
| 1990 | 6 | 0 |
| 1991 | 9 | 0 |
| 1992 | 9 | 0 |
| 1993 | 15 | 0 |
| 1994 | 25 | 0 |
| 1995 | 45 | 0 |
| 1996 | 60 | 0 |
| 1997 | 85 | 0 |
| 1998 | 124 | 0 |
| 1999 | 175 | 0 |
| 2000 | 164 | 0 |
| 2001 | 232 | 89 |
| 2002 | 330 | 411 |
| 2003 | 311 | 687 |
| 2004 | 254 | 897 |
| 2005 | 266 | 847 |
| 2006 | 351 | 816 |
| 2007 | 395 | 865 |
| 2008 | 383 | 963 |
| 2009 | 498 | 1230 |
| 2010 | 653 | 1307 |
| 2011 | 650 | 1237 |
| 2012 | 743 | 1185 |
| 2013 | 917 | 910 |
| 2014 | 910 | 957 |
| 2015 | 714 | 768 |
| 2016 | 591 | 743 |
| 2017 | 552 | 716 |
| 2018 | 486 | 606 |
| 2019 | 500 | 566 |
| 2020 | 400 | 490 |
| 2021 | 336 | 420 |
| 2022 | 223 | 336 |
| 2023 | 193 | 254 |
| 2024 | 179 | 273 |
| 2025 | 168 | 216 |
| 2026 | 75 | 145 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods for treating bone-related disorders22 Sep 2026US 12,740,963 B2University of Maryland, Baltimore
- Bi-specific fusion proteins25 Aug 2026US 12,715,937 B2Silver Creek Pharmaceuticals, Inc.
- Method of using a needle assisted injection device having reduced trigger force18 Aug 2026US 12,708,710 B2Antares Pharma, Inc.
- Pharmaceutical products and stable liquid compositions of IL-17 antibodies11 Aug 2026US 12,702,711 B2Novartis AG
- Diacylglycerol acyl transferase 2 inhibitors11 Aug 2026US 12,703,696 B2Pfizer Inc.
- Very long chain fatty acids for use in mineralization8 Oct 2026US 2026/0306434 A1Epax Norway AS
- Composition for removing and inhibiting senescent cells, and uses thereof8 Oct 2026US 2026/0306460 A1Lifeceutix Co., Ltd.
- Composition comprising homogeneous polysaccharide or derivative thereof and method of using the same to prevent and/or treat bone loss8 Oct 2026US 2026/0306529 A1
- Method for isolating fetuin-a8 Oct 2026US 2026/0308213 A1PreviPharma GmbH
- Stabilized analogues of calcitonin8 Oct 2026US 2026/0308222 A1Yissum Research Development Company of the Hebrew University of Jerusalem
Most cited
By later US patents
- Plasma protein matrices and methods for their preparation1,406US 7,009,039 B2ProChon Biotech Ltd. · 2006
- Devices and methods for treating defects in the tissue of a living being1,347US 7,166,133 B2Kensey Nash Corporation · 2007
- (20S)-1α-hydroxy-2α-methyl and 2β-methyl-19-nor-vitamin D3 and their uses1,031US 7,094,916 B2Wisconsin Alumni Research Foundation · 2006
- Solid carriers for improved delivery of active ingredients in pharmaceutical compositions930US 6,248,363 B1Lipocine Inc. · 2001
- Three dimensional cell protector/pore architecture formation for bone and tissue constructs778US 7,713,542 B2ADA Foundation · 2010